Source: United Press International
Posted: May 9, 2007 at 8:31 PM ET
Summary:
Two biotechnology companies recently reported they are close to entering clinical trials with embryonic cells. Geron plans to use cells derived from embryonic stem cells for treating spinal injuries. Advanced Cell Technology announced it has developed a technique to generate a type of progenitor cell that could move into the clinic in 2008 for treating a variety of ills.
